CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company
ATOSSA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATOS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264753208
- Phone
- 206.588.0256
- Business address
- 1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
- Former names
- ATOSSA GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-03-09 | QUAY STEVEN C President & CEO | Purchase | +15,000 | $0.37 | $6K | 4,826,858 |
| 2016-02-16 | QUAY STEVEN C President & CEO | Purchase | +15,000 | $0.53 | $8K | 4,811,858 |
| 2016-02-16 | Chen Shu-Chih Director | Purchase | +15,000 | $0.53 | $8K | 4,333,315 |
| 2016-01-19 | Chen Shu-Chih Director | Purchase | +50,000 | $0.20 | $10K | 4,318,315 |
| 2016-01-19 | QUAY STEVEN C President & CEO | Purchase | +50,000 | $0.20 | $10K | 4,796,858 |
| 2015-09-01 | Youmans Scott Chief Operating Officer | Grant or award · Stock Option (right to buy) | +50,000 | 286,217 | ||
| 2015-06-12 | Remmel H. Lawrence Director | Purchase | +5,400 | $1.30 | $7K | 9,400 |
| 2015-05-12 | Galli Stephen J Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2015-05-12 | Remmel H. Lawrence Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2015-05-12 | Steinhart Richard I Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2015-05-12 | WEAVER GREGORY L Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2015-03-16 | Destro Christopher S. SVP, Sales and Marketing | Grant or award · Stock Options | +54,625 | 54,625 | ||
| 2015-03-16 | Guse Kyle See Remarks | Grant or award · Stock Options | +190,000 | 190,000 | ||
| 2015-03-16 | Sawyer John E See Remarks | Grant or award · Stock Options | +59,265 | 59,265 | ||
| 2015-03-16 | QUAY STEVEN C President and CEO | Grant or award · Stock Options | +275,000 | 275,000 | ||
| 2014-05-06 | Carbonaro Peter J. Sr. Vice President, Operations | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2014-05-06 | Destro Christopher S. Sr. VP, Sales and Marketing | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2014-05-06 | Guse Kyle CFO & General Counsel | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2014-05-06 | Chen Shu-Chih Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2014-05-06 | Galli Stephen J Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 |
Page 7 of 9 · 168 trades